KH
Highly rated in
23
conditions
Highly rated in
23
conditions
Check Dr. Kenneth S. Hu's experience treating your condition:
About Dr. Kenneth S. Hu

Kenneth Hu is a Radiation Oncologist in New York, New York. Hu has been practicing medicine for over 28 years and is highly rated in 23 conditions, according to our data. His top areas of expertise are Tongue Cancer, Laryngeal Cancer, Throat Cancer, and Sinus Cancer. He is licensed to treat patients in New York. Hu is currently accepting new patients.

His clinical research consists of co-authoring 79 peer reviewed articles and participating in 5 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Kenneth S. Hu it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Kenneth S. Hu accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
560 1st Avenue, 2nd Floor, New York, NY 10016
Other Locations
462 First Avenue, Manhattan, New York, NY 10016
160 E 34th St, New York, NY 10016
Background & Education
Graduate Institution
Harvard Medical School, 1994
Specialties
Radiation Oncology
Licenses
Radiology in NY
Hospital Affiliations
Tisch Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma
Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
View 2 Less Clinical Trial -

79 Total Publications

Patterns of Care and Outcomes of Carcinosarcoma of the Major Salivary Glands.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors